Investigation of Oral Microflora of Infants

January 14, 2020 updated by: Zehra Beyza Erel, Inonu University

Investigation of Colonization of Streptococcus Mutans, Lactobacillus Spp. and Candida Spp. in Oral Microflora in Infancy and Transmission From the Parent to the Infant

The placement of cariogenic microorganisms in oral microflora is an important factor in dental caries. The aim of this study is to research from whom, when and how the cariogenic microorganisms are first transmitted to the infant. The investigators investigated of colonization of Streptococcus mutans, Lactobacillus spp., and Candida spp. in oral cavities of infants and their transmission to the infants.

Study Overview

Status

Completed

Detailed Description

Study sample size and design: When α = 0.05, 1-β (power) = 0.80 were taken to determine the sample volume, it was calculated that at least 46 babies should be sampled for 6 months to have an average amount of S. mutans change of 1.87 units. Considering the losses that may occur during the follow-up, the study was started by taking samples from 60 systemically healthy newborns.

The study commenced with 60 newborns and was completed with 47 infants due to losses during the follow-up. Oral swab samples were taken from 47 healthy infants within the first 24 hours after birth, at 1 month old and during the first tooth eruption. Saliva samples were taken from the mothers of all the infants and from the fathers of 20 of the infants in the last meeting.

Last interview with the parents, their oral examinations were performed, and their findings were processed as decayed (D), filled (F) and missing (M) teeth in accordance with the World Health Organization criteria, with the DMF (decayed, missing and filled) index being calculated. Furthermore, saliva samples were taken from the parents at the last interview. A questionnaire form including the sex of the infant, type of delivery, birth weight, and nutritional habits of the infant during the follow-up was filled in by gaining information from the parents on the first day and during the follow-ups.

Swab samples taken from infants with sterile swabs were transferred to the laboratory by placing sterile saline solution into dispensed 2 ml screw cap tubes. Sterile urine collection containers of 50 ml were used to collect saliva samples from the parents.

Study Type

Observational

Enrollment (Actual)

47

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Malatya, Turkey, 44280
        • Inonu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 minutes to 2 hours (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

This study was conducted in two centers - Turgut Özal Medical Center and Malatya Training and Research Hospital. Between January and May 2018, healthy newborns born in these two hospitals were followed up.

Description

Inclusion Criteria:

  • none of the infants or their families had systemic disease

Exclusion Criteria:

  • the infants or their families have systemic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acquisition of the oral streptococcus mutans in infants
Time Frame: first 24 hours after birth
Counts of oral streptococcus mutans
first 24 hours after birth
Acquisition of the oral streptococcus mutans in infants
Time Frame: at 1 month old
Counts of oral streptococcus mutans
at 1 month old
Acquisition of the oral streptococcus mutans in infants
Time Frame: 4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby
Counts of oral streptococcus mutans
4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acquisition of the oral Lactobacillus and candida spp. in infants
Time Frame: first 24 hours after birth
Counts of oral Lactobacillus and candida spp
first 24 hours after birth
Acquisition of the oral Lactobacillus and candida spp. in infants
Time Frame: at 1 month old
Counts of oral Lactobacillus and candida spp
at 1 month old
Acquisition of the oral Lactobacillus and candida spp. in infants
Time Frame: 4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby
Counts of oral Lactobacillus and candida spp
4 to 12 months depending on the first tooth eruption.This period changed according to the growth rate of the baby

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: gülsüm duruk, Inonu University
  • Principal Investigator: zehra b erel, Inonu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2018

Primary Completion (Actual)

May 20, 2018

Study Completion (Actual)

January 25, 2019

Study Registration Dates

First Submitted

January 7, 2020

First Submitted That Met QC Criteria

January 10, 2020

First Posted (Actual)

January 14, 2020

Study Record Updates

Last Update Posted (Actual)

January 18, 2020

Last Update Submitted That Met QC Criteria

January 14, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 963

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

I can think of sharing after becoming a publication in a journal

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Streptococcus Mutans

3
Subscribe